Orchestra Biomed Gets $70M from Medtronic and Ligand
Orchestra Biomed Secures $70M in Strategic Funding, Signaling Growing Confidence in Late-Stage Cardiology Programs Orchestra Biomed has secured $70...
Liminatus Pharma Launches American BNB Strategy
Liminatus Pharma, a preclinical biopharmaceutical company, is making a striking move into the cryptocurrency market, planning to acquire up...
Bio Usawa & DEK Vaccines Partner to Expand Biopharma Access in Ghana
Bio Usawa and DEK Forge Partnership to Tackle Africa’s Growing Non-Communicable Disease Burden Bio Usawa, a private biotech company...
Branded Legacy to Acquire Bio-Legacy, Advancing Nasal Drug Delivery
Branded Legacy, Inc., a diversified holdings company, is poised to enter the burgeoning naloxone and vaccine markets through a...
Vivex Completes ASCEND Trial Enrollment for Disc Degeneration
Vivex Biologics has completed patient enrollment in its ASCEND trial, a pivotal study evaluating VIA Disc NP, a novel...
Duravyu™ Phase 3 Wet AMD Trial Enrollment Complete
EyePoint Pharmaceuticals has achieved full enrollment in its LUCIA trial, the second of two pivotal Phase 3 studies evaluating...
Serina Therapeutics to Develop Novel TD Treatment
Serina Therapeutics is advancing SER-270 (POZ-VMAT2i), a once-weekly injectable vesicular monoamine transporter 2 (VMAT2) inhibitor, for tardive dyskinesia (TD)....
Bio Usawa and Sartorius Partner to Expand Biopharmaceutical Manufacturing in Africa
Bio Usawa and Sartorius Stedim Biotech Forge Partnership to Bolster Africa’s Biopharma Capabilities Bio Usawa, a Rwandan biotechnology company,...
NeuroStar Publication in JAACAP Open Shows Efficacy in Depressed Adolescents
Real-world data from the NeuroStar TrakStar Clinical Database, the largest repository of its kind for depression outcomes, reveals promising...
Sandoz to Acquire Just-Evotec Biologics in Toulouse
Sandoz’s proposed acquisition of Just-Evotec Biologics (JEB) for approximately $300 million marks a significant move to solidify its position...